International Journal of Pharma and Bio Sciences
    ISSN 0975-6299
Publication Policies

The Publication Policies of the Journal are framed in keeping with objective of the Journal which is to publish research work that is original, relevant and highly contributive to the development of the world and betterment of life in this world.

Editorial Review Policy

The Editorial Review Policies offer guidelines (Manuscript Screening Guidelines) to the Editorial Board and Peer-reviewers about effecting discharge of their respective duties. This Manuscript Screening Guidelines are updated at regular intervals on discussion with our editorial board members and peer reviewers. Read more about the editorial review policies[click here] .

Copyright Policy

All articles published in IJPBS Journal are hybrid open access articles, published and distributed under the terms of the Creative Commons Attribution 4.0 International Public License, which permits reproduction, distribution, derives and non-commercial use, provided the original work is properly cited and authors and publisher are properly identified. Read the brief summary of copyright policy[click here].

All publications of the Journal are protected by copyright laws and breach of this law is subject to legal actions. Any kind of reproduction or reference to the publications can be permitted only if the original sources of those information are properly cited. Read more about the copyright policy [click here] .

Publication Charges Waiver Policy

The main objective of the IJPBS is towards dissemination of knowledge and to develop research, and commercial gains do not form part of the main objectives. The Journal takes all possible efforts to support the authors by offering a waiver in the publication charges based on the quality of the manuscript defined by the reviewer comments, economic situation of the author etc, on authors request, but decision on the waiver would be decided by the managing editor.

Complaints Policy

The Journal will act promptly on any complaints it receives and follow due course of action as per its Complaints Policy. It ensures unbiased, fair dealing of the complaints, ensuring that both the appellant and defendant receive equal opportunities to represent their respective cases.
Read more about the complaints policy.[click here] 

Peer Review Policy

According to the Peer Review policy of the Journal every manuscript that is submitted for consideration for publication undergoes a strict, double-blind peer review process that ensures a fair, unbiased scrutiny of the author’s work. During, the double blind peer review, neither author nor the reviewer selected by IJPBS knows each other during the review process. The reviewer are requested to make a fair and objective review of all the aspects expected of a research manuscript like, content, originality, relevance of the findings, data analysis and interpretation etc, offering constructive criticism and useful suggestions and recommendations.  English language, grammatical error etc should also be considered by the reviewer for the suitability of the manuscript. Read more about the Peer Review policy.[click here] 

Ethical violations

If there is ethical violation is some way or other, the article may be rejected at any here

Corrections and Retractions

Read more about article corrections and retractions[click here] .

Manuscript Withdrawals

During peer review process or after publication, if the manuscript is found any conflict of interest from author side, or any falsification of datas or similar to these errors and asked for withdrawal of the manuscript, the manuscript would be withdrawn.
Read more about article withdrawals[click here] 

Embargo Policy

In order to ensure that there is no unwarranted access to all manuscripts that are submitted to the Journal, we follow a strict embargo policy.  The press or public will not have access to the manuscripts until they are published. All possible measures will be taken to make sure that the reviewers honour their promise to confidentiality. Journal will not take the responsibility for any breech of confidentiality either by the reviewer, editorial board member or the corresponding author towards publishing of the manuscript until it gets published in our journal but necessary action will be initiated against that party. . Read more about article Embargo Policy[click here] .

Ethical expectations

There is an ethical binding on all the members of the various departments of the Journal. Everyone is expected to perform his/her duties within certain ethical code. To read more about the ethical expectations of Editor in chief & Managing editor, Author, Publisher, Peer reviewer and publisher [click here].

Consent for identifying information

The Journal conforms to the requirements stipulated by the International Committee of Medical Journal Editors (ICMJE) with regard to consent to publish identifying information

Manuscript having datas or images or information which can identify the individual or patient will not be accepted for publication.

A written consent should be taken from the patient/individual by the author if the identity of the person such as clinical images, name, address, contact information their medical history or information if included in the manuscript. Read more about consent for identifying information Policy[read here] .

Informed consent

Authors who are submitting a research manuscript having patients study datas have to use information regarding a patient in their paper. But according to the stipulations of International Committee of Medical Journal Editors (ICMJE), such information cannot be used in manuscripts unless the author obtains informed consent from the patients/next-in-kin. Informed consent from the individual/patients who are included in the

  1. For their inclusion in the study
  2. For publishing their identity information (text , images etc)
  3. For publishing their details

Read more about consent for “Informed consent” [read here].

Dealing with unethical Allegations

The Journal upholds strong ethical values and good code of conduct. If anyone finds any unethical behaviour or misconduct of any member associated with the Journal, they can bring the matter to the notice of the Journal authorities. If the complaint is made with proper evidence, every step will be taken for a thorough and fair probe into the matter. All the rights of both the alleged defaulter and the complainant will be respected. The accused will be given opportunity to explain his/her side. Strict confidentiality will be maintained throughout the process of investigation. Decisions will be taken by the publishers in proper consultation with experts.
Read more about consent for “Dealing with unethical Allegations” [read here] .

Research on human and animal studies

The Journal’s policy insists that certain guidelines have to be followed by authors of research papers whose work deal with human subjects. The guidelines are as per the Declaration of Helsinki 1978. The author’s institutional board or any other appropriate committee should have approved of the research on human subjects and the name of this board has to be acknowledged with approval number and date. National Research Council has guidelines for the care and use of laboratory animals. Any research done on these animals should be within the permissible limits if these guidelines. All details regarding the use of these animals for experiments and other related studies should be clearly stated in the manuscript.
Read more about consent for “Research on human and animal studies” [read here].

Advertising Policy

The Journal does not promote any advertisement. Announcements about conferences, seminars, symposiums, workshops, or information about hospitals, institutes or organizations are allowed to be placed on our website for free of cost.
Read more about consent for “Advertising Policy” [read here] .

Appeal policy against Editorial decision

After the peer review process, if the Editorial Board decides to reject a manuscript, the author will be notified about the decision. But if the author thinks that it has been an unfair decision he/she has the freedom to make an appeal against the decision to the journal.
Read more about consent for “Appeal policy against editorial decision” [click here] .

Confidential Information

Strict confidentiality is maintained to matters related to manuscripts, correspondences made with authors and reviewers and complaints made. The same is expected of the Authors, Reviewers and Editorial Staff. The manuscripts, comments from the peer-reviewers, correspondences made, emails etc should not be released to any unauthorized person/body/forum/website. The journal can release the communication, emails etc for its purpose of its policies as and when need arises.

Digital Preservation Policy

The manuscript published by IJPBS Journals are in electronic format. The Published full text of the manuscript would be available in PDF format. Archiving of the earlier issues will be made in the respective web pages. All our electronic content (websites, journals, manuscripts etc.) is stored by our publisher UBI journal publishers with their designated servers and a suitable back up is made for the safety of the content if any mishap such as hacking etc happens on three different servers. Content on one server is online and accessible to the readers. The copy of the same live content is kept as a backup on two other servers. In case of failure of one server, any one of the other servers can be made online and all websites and journals will be live within less than 24-36 hours. Self-Archiving:  If the journal stops publishing, the journal domain, the website and all the content will be kept in their original form for a period of 10 years. After 10 years the content will be moved to another archive — IJPBS Full Archive — where it will be kept online and publicly accessible with same respective DOI. This archive would be created to preserve all the digital content (especially published manuscripts) perpetually.
Read more about consent for “Digital Preservation Policy”[click here] .

Hybrid Open Access Policy

The IJPBS follows hybrid open access policy which has both open access and subscription access publishing model . In  the open access publishing , the articles are online and at free of cost with respective creative commons license towards reusage of the respective article. Published open access articles are indicated in the index, abstracts  or online contents with a respective symbol. Hybrid open access has the features of publishing the article either under open access or subscription model. Both models ensures independent peer review and have been accepted for publication.

Under Hybrid open access ,

An open access publication fees is payable by the author or their research funder. This fee for the article if been paid by the author , the article will be made free open access to both subscribers and for the public under said usage permission from the date of publication and this model of publication is called Gold open access (GOA). The fee for this GOA would be $1250 USD per article.

If the author feels the GOA fee to be unaffordable or non availability of sponsors, then  a part  of GOA  fee can be paid by the author , and the article will be made open access after an embargo period and this model of publication is  called  Green open access (GrOA). This fee would be USD $950 per article. For embargo period kindly visit embargo policy. The subscription fee that author pay for Gold or Green open access makes the article open access which covers the revenue that the journal loses as result of offering our content to non-subscribers for free.

On publishing your article under subscription (either as Gold or Green open access),  your article can be viewed by scholars, universities etc who has subscriptions or who have subscribed to our journal. We ensure  articles metadatas and in citation form  will also be published in the subscription model for at respective abstract page which ensures citations . But getting published in Gold open access ensures full text published along with meta datas and in citable form from the date of publishing. Publishing under Green open access ensures the same after the respective embargo period. Authors do not worry about the citation future of their article published in the above said model as their metatags / abstract will be freely available from the date of publishing and this will ensure .

If the author finds difficult or unaffordable paying for GOA  (or)  GrOA access then the article will be published under subscription. For this, subscription  APC  (SAPC) would be charged which is much less than GOA .The fee is USD 315 / manuscript. The article will remain under subscription model until the journal releases for free open access. For details click here

The author will have an option of selecting the mode of publishing their paper in the journal. Once the manuscript is provisionally accepted, then in the acceptance email or in the invoice it will be indicted about the publishing of the manuscript in the subscription model and option will be given to  author for publishing  in Gold open access (GOA)  or Green open access (GrOA). They can communicate to the journal for further process about their option.

In publishing the manuscript under subscription model, basic or minimum fee subscription  processing fee (SAPC ) will be collected and this is to maintain the cost of processing, publishing, maintaining  etc  of article in the journal as it is unpredicted and not sure if the papers published under this model will attract any download in subscription model. Moreover , in order to face the expenses for processing and publishing those article, this fee is charged. It also contributes to the overall sustainability of the journal and the livelihoods of the  staff towards healthy maintenance of the journal. Fee waiver would also be considered or provided on case to case basis which depends on the authors request with appropriate reason for the request.




Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech SolutionsHome I Contact I Terms & Conditions